Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT06265649
Recruiting Observational

Comparison of NOM for ACLD Between Medical and Surgical Ward

NCT06265649 · tracked via the Priya Life Science Italy tracker
Sponsor
Ospedali Riuniti Trieste
Phase
Observational
Started
2024-01-01
Last updated
2025-04-04

Condition(s) studied

DiverticulitisColon DiseaseAcute Diverticulitis

Investigational drug(s) / intervention(s)

NOM

NOM: Non-operative management (NOM) for ALCD consists of lab test monitoring, fluid therapy, antibiotic therapy, abscess drainage if \>4cm, restoring a regular diet

Study summary

In Europe, patients with acute left colon diverticulitis (ALCD) are usually admitted to surgical wards even when only medical treatment is required. The study compares ALCD non-operative management (NOM) between surgical and non-surgical environments regarding clinical outcomes, hospitalization length(LOS), and follow-up.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients affected by ALCD using a contrast-enhanced CT scan at admission undergoing NOM Exclusion Criteria: * immediate indication for surgery (i.e. patients with Hinchey III or IV ALCD or septic patients with Hinchey II)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Manuela Mastronardi Trieste TS Recruiting

More Ospedali Riuniti Trieste trials in Italy

Palmitoylethanolamide and Luteolin in Patients with Acute Ischemic Stroke Starting soon
Costal Fracture Assessment for Relief and Enhancement of Quality of Life Starting soon
Evaluating Decision-making Using ChatGPT-4 Among Trainees in Surgery Starting soon

Other trials for the same condition

AIDE: Decision Support for Anastomosis or Colostomy in Emergency Surgery for Complicated Acute Diverticulitis Starting soon
Web-based International Register of Emergency Surgery and Trauma Recruiting
Prospective Observational Analysis of Circulating Endocan Levels in Patients Presenting With Acute Diverticulitis Starting soon
RObotic Versus LAparoscopic Colectomy for DIverticulitis. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06265649 on ClinicalTrials.gov ↗ ← All trials in Italy